Safety of EVO ICL Implantation With an Ophthalmic Viscosurgical Device-Free Technique in the Early 24 h After Surgery

Zhe Zhang, Lingling Niu, Jing Zhao, Huamao Miao, Zhuoyi Chen, Yang Shen, Xun Chen, Yuhao Ye, Xiaoying Wang, Xingtao ZhouFrontiers in Medicine 2021 · DOI

TL;DR

This study introduces and evaluates a novel "non-OVD" technique for implanting EVO ICLs, eliminating the use of ophthalmic viscosurgical devices (OVDs) altogether. The findings suggest this OVD-free approach is safe and efficient, leading to shorter surgery times and reduced early postoperative intraocular pressure spikes compared to a "minimum OVD" technique, without compromising visual outcomes or corneal health.

What Problem Does This Paper Address?

Myopia, or nearsightedness, is a widespread vision problem. Implantable Collamer Lenses (ICLs) are a popular and effective surgical solution for correcting myopia. Traditionally, ophthalmic viscosurgical devices (OVDs) are used during ICL implantation to maintain anterior chamber stability and protect the corneal endothelium. However, retained OVDs can lead to significant postoperative complications, most notably early spikes in intraocular pressure (IOP). These IOP spikes can cause corneal edema, pain, and potentially more serious issues like retinal artery occlusion or anterior ischemic optic neuropathy. While a "minimum OVD" technique has been developed to mitigate these risks, this paper explores an even more advanced approach: completely eliminating OVDs. The challenge is to achieve this OVD-free implantation safely and effectively, ensuring comparable or improved outcomes to existing methods.

Methods

The researchers conducted a prospective study comparing two techniques for EVO ICL implantation:

  • Non-OVD Technique: This novel approach completely avoids the use of OVDs and balanced salt solution (BSS) in the anterior chamber during surgery. The ICL is inserted through a small corneal incision, and the surgeon relies on the self-sealing nature of the incision and the properties of the ICL itself to maintain anterior chamber stability.
  • Min-OVD Technique: This served as the control group. In this method, a minimal amount of OVD is used to assist with ICL insertion and positioning, followed by a BSS wash to remove the OVD.

A total of 90 patients (180 eyes) were enrolled. 100 eyes were treated with the non-OVD technique, and 80 eyes were treated with the min-OVD technique. The success rate for the non-OVD technique in the initial attempt was 55.6%; eyes that were not successfully implanted with the non-OVD technique were then treated with the min-OVD technique.

Key outcome measures included:

  • Intraocular Pressure (IOP): Measured at 1, 2, 3, and 24 hours postoperatively.
  • Visual Acuity: Assessed preoperatively and at 1 day postoperatively.
  • Corneal Endothelial Cell Density (ECD): Measured preoperatively and at 24 hours postoperatively.
  • Corneal Densitometry: Evaluated preoperatively and at 1 day postoperatively to assess corneal clarity and potential structural changes.
  • Operation Time: Recorded for each surgery.

Statistical analyses were performed using SPSS, with Student's t-tests for baseline comparisons and repeated-measures ANOVA for postoperative outcomes.

Datasets

Not discussed in the paper. The study involved data collected from 90 consecutive patients undergoing ICL implantation at the Eye and ENT Hospital of Fudan University.

Key Insights and Ideas

  • The "Aha!" Moment: OVDs are not always necessary. The core insight is that ICL implantation can be performed safely and effectively without any OVDs, challenging the long-held assumption that they are essential for anterior chamber stability and endothelial protection.
  • Reduced IOP Spikes: Eliminating OVDs significantly reduces the risk of early postoperative IOP spikes. This is a critical finding, as these spikes are a major source of complications.
  • Efficiency Gains: The non-OVD technique dramatically shortens surgery time, which can lead to improved patient comfort and increased surgical throughput.
  • Corneal Health Maintained: Despite the absence of OVDs, the non-OVD technique did not negatively impact corneal endothelial cell density or cause significant changes in corneal densitometry, suggesting it's as safe for corneal health as the min-OVD approach.
  • Learning Curve Consideration: While effective, the non-OVD technique requires a learning curve for surgeons, implying that mastery of traditional techniques is a prerequisite.

Key Results

  • Operation Time: The non-OVD group had a significantly shorter operation time (63.68 ± 27.35 s) compared to the min-OVD group (144.8 ± 33.27 s) (P < 0.0001).
  • Intraocular Pressure (IOP):
    • The min-OVD group showed significantly higher IOP at 1, 2, and 3 hours postoperatively compared to their preoperative levels.
  • The non-OVD group did not show significant IOP increases at these time points.
  • Crucially, the non-OVD group had significantly lower IOP than the min-OVD group at 1 hour (P = 0.01) and 2 hours (P = 0.013) postoperatively.
  • No significant differences in IOP were observed between the groups at 24 hours.
  • The need for paracentesis tap and IOP control drugs was significantly lower in the non-OVD group.
  • Visual Outcomes: No significant difference was found in visual outcomes (P = 0.54) between the two groups.
  • Corneal Endothelial Cell Density (ECD): No significant difference was found in ECD (P = 0.78) between the groups at any follow-up time point.
  • Corneal Densitometry: Temporal corneal densitometry was significantly lower in the non-OVD group compared to the min-OVD group 1 day after surgery (P = 0.0063). This suggests less impact on the corneal tissue at the incision site.

Limitations and Future Work

  • Learning Curve: The authors acknowledge that the non-OVD technique has a learning curve and is best learned after mastering traditional surgical techniques. Further training is recommended for ophthalmologists.
  • Long-Term Ocular Biometrics: The study focused on early (24-hour) outcomes. The authors suggest that a long-term study is needed to monitor changes in ocular biometrics over time.
  • Potential for Situational Switching: While the non-OVD technique is generally safe, surgeons should be prepared to switch to a conventional method if any situation arises that compromises anterior chamber stability.

Future work should focus on long-term follow-up to fully assess the sustained safety and efficacy of the non-OVD technique and its impact on ocular biometrics.

Summary updated

Abstract

<b>Purpose:</b> To compare the safety of the non-ophthalmic viscosurgical device (OVD) technique with that of the minimum OVD technique in EVO Implantable Collamer Lens (EVO-ICL) implantation. <b>Methods:</b> A total of 180 eyes of 90 consecutive patients were enrolled in the study, of which 100 eyes of 50 patients were treated with non-OVD technique, with a 55% success rate. The remaining 80 eyes of 40 patients were treated with min-OVD technique, so they were classified into the min-OVD group. Preoperative and postoperative intraocular pressure (IOP) measurements were collected and analyzed at 1, 2, 3, and 24 h. Visual acuity, corneal endothelial cell density (ECD), and corneal densitometry 24 h postoperatively were evaluated. <b>Results:</b> No significant difference was found in visual outcomes (<i>P</i> = 0.54) or ECD (<i>P</i> = 0.78) between the two groups. The operation time was significantly shorter in the non-OVD group (<i>P</i> < 0.0001). The IOP was significantly higher at 1 h (<i>P</i> < 0.0001), 2 h (<i>P</i> < 0.0001) and 3 h (<i>P</i> = 0.0045) postoperatively in the min-OVD group. The non-OVD group had significantly lower IOP than the min-OVD group at 1 h (<i>P</i> = 0.01) and 2 h (<i>P</i> = 0.013) postoperatively. The temporal corneal densitometry in the non-OVD group were significantly lower than those in the minimum group (<i>P</i> = 0.0063) 1 day after surgery. <b>Conclusion:</b> The non-OVD technique is safe and efficient for ICL implantation. It can be a safer method of ICL implantation in that it completely eliminates ophthalmic viscoelastic devices related complications without causing additional complications in short term.
BibTeX
@inproceedings{zhang2021safety,
  author = {Zhe Zhang and Lingling Niu and Jing Zhao and Huamao Miao and Zhuoyi Chen and Yang Shen and Xun Chen and Yuhao Ye and Xiaoying Wang and Xingtao Zhou},
  title = {{Safety of EVO ICL Implantation With an Ophthalmic Viscosurgical Device-Free Technique in the Early 24 h After Surgery}},
  booktitle = {Frontiers in Medicine},
  year = {2021},
  doi = {10.3389/fmed.2021.764653},
}
Figure